Open AccessSunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance
Author(s) -
YenYang Chen,
ChunNan Yeh,
ChiTung Cheng,
Tsung-Wen Chen,
KunMing Rau,
Yi-Yin Jan,
MiinFu Chen
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i16.2113
Subject(s) - sunitinib , medicine , gist , neutropenia , gastroenterology , imatinib mesylate , imatinib , adverse effect , anemia , stromal tumor , oncology , cancer , stromal cell , chemotherapy , myeloid leukemia
To report preliminary results of the efficacy and safety of sunitinib in the management of Taiwanese gastrointestinal stromal tumors (GIST) patients facing imatinib mesylate (IM) intolerance or failure.